Hi all,
I have taken the unusual step to reply to comments on my forthcoming departure from Prima BioMed. Anything I write here is not material from the corporate perspective, and is not a new announcement. I sincerely appreciate all the support from our shareholders, who I have come to respect and to like over the years. I am a shareholder in Prima BioMed and will continue to be so until the company is successful. CVac in my opinion is a major breakthrough for patients with ovarian cancer, and potentially other tumours, and I believe the CANVAS study will confirm that opinion. I truly believe that our CEO, Mr. Lehman, has the best interests of the company and our shareholders at heart. I am, and will continue to be, a staunch supporter of the company.
My best to all of you.
Neil Frazer
Ann: Change in Senior Management , page-27
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.020(7.41%) |
Mkt cap ! $421.8M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 29.5¢ | 27.0¢ | $1.138M | 3.985M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 63444 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 65000 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |